CRISPR/Cas9 technology generated a 2-bp insertion (AT) in exon 2 that creates an in-frame early TAA stop codon 386 bp downstream of the ATG. qRT-PCR of quadriceps shows a significant reduction in transcript level and Western blot analysis shows loss of protein in skeletal muscle of homozygotes.